{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:09:39Z","timestamp":1785902979887,"version":"3.56.0"},"reference-count":17,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s244102","type":"journal-article","created":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T22:40:55Z","timestamp":1585521655000},"page":"1257-1262","source":"Crossref","is-referenced-by-count":15,"title":["<p>Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma<\/p>"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Liya","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5106-5176","authenticated-orcid":true,"given":"Xiaopeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000370","volume":"27","author":"Zhang","year":"2016","journal-title":"Anticancer Drugs"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1200\/JCO.2017.73.3675","volume":"35","author":"Hsu","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3390\/cancers6041925","volume":"6","author":"Wang","year":"2014","journal-title":"Cancers"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.2147\/OTT","volume":"11","author":"Zhao","year":"2018","journal-title":"Onco Targets Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3892\/mco.2015.529","volume":"3","author":"Wen","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray","year":"2018","journal-title":"CA"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ijrobp.2004.11.002","volume":"62","author":"Yeh","year":"2005","journal-title":"Int J Radiat Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.radonc.2011.12.028","volume":"104","author":"Tuan","year":"2012","journal-title":"Radiother Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","volume":"110","author":"Lee","year":"2014","journal-title":"Radiother Oncol"},{"key":"ref11","first-page":"814910","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/S0140-6736(16)31388-5","volume":"388","author":"Zhang","year":"2016","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.2147\/CMAR.S165804","volume":"10","author":"Shuai","year":"2018","journal-title":"Cancer Manag Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.1158\/0008-5472.CAN-10-0111","volume":"70","author":"Yan-jun","year":"2010","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/1471-2407-10-529","volume":"10","author":"Li","year":"2010","journal-title":"BMC Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.oraloncology.2014.04.007","volume":"50","author":"Long","year":"2014","journal-title":"Oral Oncol"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=57111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=57111","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T22:40:58Z","timestamp":1585521658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/safety-and-feasibility-of-low-dose-apatinib-combined-with-s-1-as-the-s-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":17,"URL":"https:\/\/doi.org\/10.2147\/dddt.s244102","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}